OOIR: Observatory of International Research

Papers

(The TQCC of Personalized Medicine is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness	17
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension	17
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing	15
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia	15
Pharmacogenomics education in China and the United States: advancing personalized medicine	13
An evidence gap map of the personalized medicine in bladder cancer	11
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population	11
Predictive value of miR-132-3p for the onset of sepsis-induced acute kidney injury and its functional role during disease development	10
Precision acute medical care through “-omic” analyses: a scoping review	8
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis	8
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer	8
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?	8
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease	8
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis	8
Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis	7
Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models	6
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar	6
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study	6
MYC variant at 8q24 increases susceptibility to urinary bladder cancer: a meta-analysis of 53,957 individuals	6
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation	6
Polygenic risk scores to refine Breast cancer screening and prevention strategies	6
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries	5
Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology	5
Leveraging circulating microRNAs for personalized disease-modifying therapies in type 1 diabetes	5
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam	5

Association of a common SOD gene variant with ARHL risk: analysis by age, hearing threshold, and enzyme activity	5
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head	5
Looking Back Over 2023 and Welcome to the 21 ^st Issue of Personalized Medicine	5
Digital biomarkers in chronic disease management: a systematic review of personalization and ethical challenges	5
Machine learning–enabled early risk stratification of β-Iactam–induced electrolyte imbalances	4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device	4
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System	4
Association between CYP11B2 rs1799998 genetic variant with essential hypertension and antihypertensive response	4
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population	4
Development of Competency-based Online Genomic Medicine Training (COGENT)	4
Genomics and the early diagnosis of lung cancer	4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead	4
Regional disparities in access to gene therapies in the European Union, the United States, Japan, and China	4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation	4
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK	4
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus	4
Evaluation of pharmacogenomic information in drug labeling: a case study from Jordan	3
Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice	3
The correlation between the polymorphism of lysolecithin acyltransferase (MBOAT7) rs641738 and liver fibrosis	3
The norepinephrine dosing dilemma in septic shock: a narrative review	3
Low Rate of Complications in Nipple-Sparing Mastectomy for Patients with BRCA1 and BRCA2 Mutation	3
Association of miR-21 rs1292037 polymorphism with congenital heart disease susceptibility in Chinese children	3
From genomes to metabolomes: adaptive science in personalized medicine	3
Global harmonization in advanced therapeutics: balancing innovation, safety, and access	3
Pharmacogenomics of Lipid-Lowering Agents: the Impact on Efficacy and Safety	3
Genetic and non-genetic factors influencing the therapeutic response of valproic acid in pediatric epileptic patients	3
Recent Advances in Personalized Cancer Immunotherapy with Immune Checkpoint Inhibitors, T Cells and Vaccines	3
The genetic association of IL-17A rs8193036 with the susceptibility to Alzheimer’s disease	3
Lung cancer, platinum analog-based frontline treatment and pharmacogenetic limitations	3
Development of a computer-based tool to obtain a family health history in Vietnam	3
A rare likely pathogenic HLA-DRB1 variant with compromised immunity in severe COVID-19 patient and in-hospital mortality	3
A Real-World Analysis of Tyrosine Receptor Kinase Inhibitor-Related Toxicities in Cancer Treatment	3
Tailoring pediatric vancomycin doses: achieving therapeutic levels and minimizing toxicity in oncology patients	3